Stocks
Blueprint Medicines Corporation (BPMC) EBITDA US GAAP (year values) |
||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | |||
| EBITDA, bln rub | ? | 308.7 | -628.3 | -515.4 | -470.4 | 19.2 | -131.1 | |
| Changes by years, y/y, % | -187% | -304% | -18% | -9% | -104% | |||
Blueprint Medicines Corporation. EBITDA US GAAP, bln rub
Blueprint Medicines Corporation. EBITDA US GAAP, changes, %
Blueprint Medicines Corporation. EBITDA US GAAP, sum by quarters, bln rub
Blueprint Medicines Corporation (BPMC) EBITDA US GAAP (quarter values) |
||||||||
| FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 109.2 | -29.5 | -33.4 | -27.1 | -41.1 | -131.1 | |
| Changes by years, y/y, % | -198% | -74% | -71% | -74% | -138% | |||
| Changes by quarters, q/q, % | -205% | -127% | +13% | -19% | +52% | |||
